Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial – Endpoints News
Roche details non-inferiority of BTK inhibitor in multiple sclerosis trial Endpoints NewsRO: Fenebrutinib matched ocrelizumab in slowing PPMS progression,…